All companies
Visit website
OPTICYTE
OperatingOpticyte, Inc.
Healthcare · Technology · Founded 2016
Early detection to prevent organ failure and save lives
Post-money valuation ⓘ
$12.4M
As of Jul 2025 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$234,540
Across 1 round since 2024
Latest share price
$0.33
Reg CF Offering (2024) offering price
Financials
FY2022–FY2025 · from SEC filings · hover any figure for its source$0
−$138K
2022
$0
−$587K
2023
$0
−$438K
2024
$0
−$531K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
-$137,784
-$587,265
-$438,291
-$531,002
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$124,916
$193,310
$132,478
$91,346
Accounts receivable
$0
$0
$0
$0
Total assets
$127,751
$196,566
$132,478
$91,346
Short-term debt
$392,789
$2,257,331
$0
$3,214,457
Long-term debt
$1,721,250
$495,000
$0
$0
Total liabilities
$2,114,039
$2,752,331
$0
$3,214,457
Other
Headcount
—
1
2
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.4M
post-money
Reg CF Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $234.5K / $1.2MInvestors 202Post-money $12.4M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 2 annual reports (FY2024–FY2025)
202 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001718984Share price $0.33
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.